# Case Report: Biallelic PADI6 frameshift variants contribute to preimplantation embryonic lethality

**Authors:** Shun-Tao Jiao, Zi-Hui Tan, Tian-Ying Wei, Ge-Han Zhang, Ti-Ling Hu, Song-Jun Li, Ya-Ping Tian, Jia-En Liu, Hua-Ying Hu

PMC · DOI: 10.3389/fgene.2026.1667814 · Frontiers in Genetics · 2026-03-11

## TL;DR

This case report identifies two new PADI6 gene mutations linked to preimplantation embryonic arrest, a cause of female infertility.

## Contribution

Reports a novel compound heterozygous PADI6 variant combination associated with preimplantation embryonic lethality.

## Key findings

- Two biallelic frameshift PADI6 variants were identified in a patient with preimplantation embryonic lethality.
- Both variants cause loss of PADI6 protein function and reduced protein abundance.
- The mutations disrupt the C-terminal domain and alter protein structure significantly.

## Abstract

Preimplantation embryonic lethality (PREMBL) is a major cause of female infertility, characterized by early embryonic arrest. Homozygous or compound heterozygous mutations in PADI6 underlie preimplantation embryonic lethality-2 (PREMBL2). This study aims to conduct a systematic genetic investigation on a case with PADI6 biallelic variants.

A patient clinically diagnosed with PREMBL was systematically evaluated via chromosomal karyotyping analysis, high-resolution chromosomal microarray analysis (CMA), whole-exome sequencing (WES), molecular dynamics analysis (MD), immunofluorescence (IF), and Western blotting (WB) to identify PREMBL-associated variants.

WES identified two biallelic frameshift variants in PADI6: c.707dupT (L237Afs*24) and c.2009_2010delAG (E670Gfs*48). MD, IF, and WB analyses demonstrated that: The L237A variant generates a 259-aa truncated protein lacking the essential C-terminal domain. The E670G variant produces a 716-aa elongated protein with significant C-terminal structural alterations. Both variants cause complete loss of protein function and markedly reduced abundance.

This study implicates a previously unreported compound heterozygous combination of the PADI6 variants c.707dupT and c.2009_2010delAG as the potential genetic basis of PREMBL2 in this individual, based on their predicted disruptive effects. However, as a single-case study, these findings cannot be generalized. Future research should focus on validating these variants in additional patients and functionally characterizing their effects to definitively establish causality and understand their role in early embryonic arrest.

## Linked entities

- **Genes:** PADI6 (peptidyl arginine deiminase 6) [NCBI Gene 353238]
- **Diseases:** preimplantation embryonic lethality (MONDO:0014783), PREMBL2 (MONDO:1010200)

## Full-text entities

- **Genes:** PADI6 (peptidyl arginine deiminase 6) [NCBI Gene 353238] {aka OZEMA16, PREMBL2, hPADVI}
- **Diseases:** PREMBL (OMIM:617234), female infertility (MESH:D007247), embryonic arrest (MESH:D018236)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** c.707dupT, L237A, E670Gfs*48

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13012707/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13012707/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC13012707/full.md

---
Source: https://tomesphere.com/paper/PMC13012707